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ORIGINAL ARTICLE
Background/Aims: Dilutional hyponatremia associated with liver cirrhosis is caused by impaired free water
clearance. Several studies have shown that serum sodium levels correlate with survival in cirrhotic patients. Little
is known, however, regarding the relationship between the degree of dilutional hyponatremia and development of
cirrhotic complications. The aim of this study was to evaluate the association between the serum sodium level
and the severity of complications in liver cirrhosis.
Methods: Data of inpatients with cirrhotic complications were collected retrospectively. The serum sodium levels
and severity of complications of 188 inpatients were analyzed.
Results: The prevalence of dilutional hyponatremia, classified as serum sodium concentrations of ≤135 mmol/L,
≤130 mmol/L, and ≤125 mmol/L, were 20.8%, 14.9%, and 12.2%, respectively. The serum sodium level was
strongly associated with the severity of liver function impairment as assessed by Child-Pugh and MELD scores
(p<0.0001). Even a mild hyponatremia with a serum sodium concentration of 131-135 mmol/L was associated
with severe complications. Sodium levels less than 130 mmol/L indicated the existence of massive ascites (OR,
2.685; CI, 1.316-5.477; p=0.007), grade III or higher hepatic encephalopathy (OR, 5.891; CI, 1.490-23.300;
p=0.011), spontaneous bacterial peritonitis (OR, 2.562; CI, 1.162-5.653; p=0.020), and hepatic hydrothorax (OR,
5.723; CI, 1.889-17.336; p=0.002).
Conclusions: Hyponatremia, especially serum levels ≤130 mmol/L, may indicate the existence of severe
complications associated with liver cirrhosis. (Korean J Intern Med 2009;24:106-112)
Keywords: Hyponatremia; Liver cirrhosis
Received: July 17, 2008
Accepted: September 22, 2008
Correspondence to June Sung Lee, MD
Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, 2240 Daehwa-dong, Seo-gu, Goyang 411-706, Korea  
Tel: 82-31-910-7200, Fax: 82-31-910-7219, E-mail: jsleemd@paik.ac.kr 
*This work was supported by a 2007 Inje University research grant.
INTRODUCTION
Intractable ascites, severe hyponatremia, and decreased
arterial pressure are clinical findings seen in patients
with advanced cirrhosis. These conditions occur as a result
of high serum levels of renin/aldosterone owing to portal
hypertension, a decreased vascular response to vasoactive
drugs, and a reduced solute-free water clearance [1-4].
According to several recent studies, hyponatremia occurring
as a result of a reduced solute-free water clearance was a
key prognostic factor in patients with liver cirrhosis when
hyponatremia was incorporated into the MELD score
[5-9]. Hyponatremia is a common abnormal finding
in approximately 57% of hospitalized patients with
chronic liver disease and in 40% of outpatients with liver
disease [1,10]. To date, no studies have been conducted
to evaluate the prevalence of hyponatremia in Korean
hospitalized patients with liver cirrhosis. In fact, no studies
have evaluated the association between serum sodium
levels and the occurrence and severity of complications
due to liver cirrhosis. Given the need for further studies
regarding this relationship, we conducted this study toKim JH, et al. Clinical significance of serum sodium level in liver cirrhosis    107
evaluate the prevalence of hyponatremia, to examine
whether serum sodium levels correlate with the presence
and severity of cirrhotic complications, and to estimate
survival rates in patients hospitalized with complications
due to liver cirrhosis.
METHODS
Subjects
Patients who were hospitalized with complications
due to liver cirrhosis during a 1-year period between 1
January and 31 December 2004 at Ilsan Paik Hospital
of Inje University, Korea were included in this study, if
a retrospective chart analysis and follow-up telephone
call were obtainable. For patient was admitted more
than twice during the study period, the medical record of
the first admission was collected. A diagnosis of liver
cirrhosis was limited to cases with laboratory and clinical
findings that met the proper diagnostic criteria [11].
Patients with hepatocellular carcinoma present at
admission and during the follow-up period were excluded.
Patients using diuretics within a 1-month period before
admission and antiviral drugs at any time of survival
period were also excluded from the current study. As
causative factors for liver cirrhosis, chronic hepatitis B
was diagnosed in cases with detectable hepatitis B sur-
face antigen, and chronic hepatitis C was diagnosed in
patients positive for anti-HCV antibody. Patients who had
ingested alcohol daily at a dose of >80 g for more than 10
years in the absence of other causative factors such as
drugs or evidence of a viral infection were defined as
having alcoholic liver cirrhosis. Other cases were classified
as ‘others’.
Study design
Based on the serum sodium concentration measured
at the time of admission, patients were divided into three
groups: serum sodium ≤130 mmol/L, serum sodium
between 131 and 135 mmol/L, and serum sodium ≥136
mmol/L. Complications included simple ascites, hepatic
encephalopathy, spontaneous bacterial peritonitis, hepatic
hydrothorax, infection, hepatorenal syndrome, esophageal
and gastric varices, upper gastrointestinal bleeding due to
varices, and intractable ascites. Ascites, hepatic ence-
phalopathies, and esophageal varices were classified based
on severity. Ascites was classified as follows: grade I,
ascites observed on imaging study but presence is unclear
on physical examination; grade II, ascites easily recognized
on gross examination and palpation; and grade III, severe
abdominal distention concurrently present on gross
examination and large-volume paracentesis performed for
therapeutic purposes [12]. Cases of hepatic encephalopathy
higher than grade III based on the West Haven criteria
were determined to be severe, and other cases were all
determined to be mild [13]. Presence of varix was described
only the case endoscopic exam was done between 3 month
before and after hospitalization. Esophageal varices were
classified by size and shape based on endo-scopic findings,
as follows: F1, a linear, small sized varix, F2, a beaded,
medium sized varix, and F3, a nodular, large varix [14].
Infection was defined in patients hospitalized with
infectious diseases except for spontaneous bacterial
peritonitis. In cases of hepatic hydrothorax and gastric
varices, only the presence of such complications was
verified. The concurrent presence of other complications
was also examined in accordance with the treatment
guidelines of the Korean Association for the Study of the
Liver [15]. When death was confirmed on a retrospective
analysis of medical records and a telephone interview, the
period ranging from the date of hospitalization to death
was considered as the survival period.
Statistical analysis
Statistical analysis was performed using SAS. Statistical
methods included the Chi-square test and ANOVA. A
p value <0.05 was considered statistically significant.
To obtain the distribution curve for the survival time
depending on the serum sodium concentration at the time
of admission, an estimated value of Kaplan-Meier was
calculated, and differences in survival time were analyzed
using the log-rank test. A hazard ratio for the concurrent
presence of complications depending on the severity of
hyponatremia was obtained using logistic regression
analysis. 
RESULTS
Patient characteristics
In the current study, we analyzed 188 inpatients with
liver cirrhosis who were hospitalized with complications
such as simple ascites, spontaneous bacterial peritonitis,
intractable ascites, hepatorenal syndrome, hepatic
encephalopathy, variceal bleeding, hepatic hydrothorax,
and infection. Patients in our series had a mean age of108 The Korean Journal of Internal Medicine Vol. 24, No. 2, June 2009
55.8±11.6 years (range, 29-82 years) and consisted of 132
men (70.2%) and 56 women (29.8%). Causative factors
for liver cirrhosis included chronic hepatitis B (113 cases,
60.1%), chronic hepatitis C (14 cases, 7.5%), alcoholic
liver disease (51 cases, 27.1%), and other diseases (10
cases, 5.3%). The mean Child-Pugh score was 9.4±1.8
(range, 5-15); the mean MELD score, 15.3±5.1 (range, 5-
36); and mean serum sodium concentration, 134.6±6.6
mmol/L (range, 115-147 mmol/L) (Table 1). Based on the
diagnostic criteria for hyponatremia in patients with
serum sodium concentrations ≤135 mmol/L and who
were hospitalized with complications due to liver cir-
rhosis, 90 patients (47.9%) were noted to have concurrent
hyponatremia. The proportion of patients with severe
hyponatremia (serum sodium, ≤130 mmol/L) was 27.1%.
Liver function and concurrent complications
based on serum sodium concentration
Based on the serum sodium concentration at the time
of admission, patients were assigned to three groups:
serum sodium ≤130 mmol/L (n=51, 27.1%), serum
sodium between 131 and 135 mmol/L (n=39, 20.8%),
and serum sodium ≥136 mmol/L (n=98, 52.1%). There
were no significant differences in gender, age, or causative
factors for liver cirrhosis among the three groups. The
mean Child-Pugh scores for the groups were 10.5±1.6,
9.8±1.7, and 8.7±1.6, respectively, and the mean MELD
scores were 17.2±5.1, 16.3±5.2, and 13.9±4.6, respectively.
These scores indicate that as hyponatremia became more
severe, liver function declined (Table 2). Complications
due to liver cirrhosis, including ascites, spontaneous
bacterial peritonitis, hepatic hydrothorax, and hepatic
encephalopathy, had significantly different frequencies
among the three groups, whereas the frequencies of other
complications such as intractable ascites, hepatorenal
syndrome, variceal bleeding, hepatic hydrothorax,
infection, esophageal varices, and gastric varices did not
differ significantly among the three groups (Table 3). The
severity of ascites and hepatic encephalopathy depending
on the serum sodium concentration differed significantly
among the three groups, but the severity of varices
depending on the serum sodium concentration was not
significantly different among the three groups (Table 4).
Risk for developing complications based on
serum sodium concentration
Based on the above results, the risks for developing
ascites, spontaneous bacterial peritonitis, hepatic
hydrothroax, and hepatic encephalopathy depending
on the serum sodium concentration were examined.
Patients with a serum sodium concentration ≤130
mmol/L, as compared with serum sodium ≥136 mmol/L
had a significantly increased risk for developing com-
plications: 2.708 (95% CI=1.034-7.092, p=0.043) for
ascites, 2.339 (95% CI=1.138-4.808, p=0.021) for hepatic
encephalopathy, 2.562 (95% CI=1.162-5.653, p=0.020)
for spontaneous bacterial peritonitis, and 5.723 (95%
CI=1.689-17.336, p=0.002) for hepatic hydrothorax.
Cases with mild hyponatremia (serum sodium between
131 and 135 mmol/L) as compared with serum sodium
≥136 mmol/L, had a tendency of increased risk for
developing the above complications, although this
relationship was not statistically significant (Table 5).
Patients with serum sodium concentration ≤130
mmol/L, risks of developing severe ascites and hepatic
encephalopathy of higher than Grade III were 2.658
(95% CI=1.316-5.447, p=0.007) and 5.891 (95% CI=1.49-
23.3, p=0.011). Patients with mild hyponatremia didn’t
show a statistical significance in the risk for developing
severe ascites and hepatic encephalopathy of higher than
Table 1. Basal characteristics of the patients
Characteristic Value
Gender (M/F) 132/56
Age, yr (mean±SD) 55.8±11.6 
Cause of cirrhosis, n (%)
HBV 113 (60.1%)
HCV 14 (7.5%)
Alcohol 51 (27.1%)
Others 10 (5.3%)
Child-Pugh class, n (%)
Class A 12 (6.4%)
Class B 84 (44.7%)
Class C 92 (48.9%)
MELD score (mean±SD) 15.3±5.1
Serum sodium (mmol/L, mean±SD)  134.6±6.6
Complications
Ascites 151 (80.3%)
Hepatic encephalopathy 60 (31.9%)
Spontaneous bacterial peritonitis  45 (23.9%)
Hepatic hydrothorax 23 (12.2%)
Infection 15 (8%)
Hepatorenal syndrome  6 (3.2%)
Esophageal varix 152 (80.9%)
Gastric varix 46 (24.5%)
Variceal bleeding 56 (29.8%)
Intractable ascites 10 (5.3%)Kim JH, et al. Clinical significance of serum sodium level in liver cirrhosis    109
Grade III. These results indicate an association between
the severity of hyponatremia and the risk for developing
severe ascites and hepatic encephalopathy (Table 5). 
Survival rate according to serum sodium
concentration
The 3-year survival rate was 47.2% in patients with a
serum sodium ≥136 mmol/L, 16.6% in patients with a
serum sodium of 131-135 mmol/L, and 33.3% in patients
with a serum sodium ≤130 mmol/L. The mean survival
periods were 24.9, 12.9 and 17.5 months, respectively.
The survival rate was significantly correlated with the
serum sodium concentration (p=0.0049), (Fig. 1).
DISCUSSION
Hyponatremia is an electrolyte imbalance that commonly
occurs in hospitalized patients. Most cases are dilutional
hyponatremia caused by the impairment of solute-free
water clearance [16]. Hyponatremia resulting from the
impairment of solute-free water excretion is commonly
accompanied by portal hypertension [10]. In recent years,
hyponatremia has attracted interest as a possible
prognostic factor for liver cirrhosis. To date, no Korean
studies have been conducted to examine its prevalence or
the concurrent presence of its complications. We conducted
this study to examine the prevalence of hyponatremia and
its complications in Korean patients hospitalized with
Table 2. Characteristics of patients according to serum sodium concentration
Characteristic ≤130 mmol/L 131-135 mmol/L ≥136 mmol/L p value
(n=51) (n=39) (n=98)
Gender
Male 34 26 72 0.59
Female 17 13 26
Age (year*) 57.3±11.5 52.6±11.5 56.2±11.5 0.14
Etiology
HBV 37 25 51
HCV 4 4 6 0.16
NonB/NonC 2 2 6
Alcohol 8 8 35
Child-Pugh score* 10.5±1.6 9.8±1.7 8.7±1.6 <0.0001
Child-Pugh class 
Class A 1 1 10
Class B 12 16 56 <0.0001
Class C 38 22 32
MELD score* 17.2±5.1 16.3±5.2 13.9±4.6 <0.0001
*Mean±SD
Table 3. Frequency of complications by serum sodium concentration
Complication ≤130 mmol/L 131-135 mmol/L ≥136 mmol/L p value
(n=51) (n=39) (n=98)
Ascites 45 (88.2%) 34 (87.2%) 72 (73.4%) 0.048
SBP 17 (33.3%) 12 (30.7%) 16 (16.3%) 0.037
Intractable ascites 5 (9.8%) 1 (2.5%) 4 (4%) 0.232
HRS 2 (3.9%) 1 (2.5%) 3 (3%) 0.931
H. encephalopathy 22 (43.1%) 14 (35.8%) 24 (24.4%) 0.018
Varix bleeding 13 (25.4%) 11 (28.2%) 32 (32.6%) 0.352
H. hydrothorax 12 (23.5%) 6 (15.3%) 5 (5.1%) 0.004
Infection 5 (9.8%) 2 (5.1%) 8 (8.1%) 0.716
Esophageal varix 42 (82.3%) 30 (76.9%) 80 (81.6%) 0.778
Gastric varix 9 (17.6%) 7 (17.9%) 30 (30.6%) 0.124
SBP, spontaneous bacterial peritonitis; HRS, hepatorenal syndrome; H. encephalopathy, hepatic encephalopathy; H. hydrothorax,
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liver cirrhosis.
In a review of a previously conducted multi-center study
in overseas countries, 997 patients with liver cirrhosis
and concurrent ascites, who were under the care of
hepatologists in hepatology outpatient clinics, were
assigned to three groups based on serum sodium concen-
tration, in a manner similar to that of the current study.
The prevalence of hyponatremia at a serum sodium ≤135
mmol/L was 49.4%. Concurrent complications such as
severe ascites, impaired renal function, hepatic ence-
phalopathy, spontaneous bacterial peritonitis and
hepatorenal syndome, except for gastrointestinal
bleeding, occurred with a higher probability in cases of
severe hyponatremia (serum sodium ≤130 mmol/L) [1].
In a study with 156 patients hospitalized with liver
cirrhosis, the prevalence of hyponatremia, based on a
serum sodium concentration ≤130 mmol/L, was 29.8%,
and hyponatremia was significantly correlated with
infection and ascites [17]. In the present study, conducted
in patients hospitalized with complications due to liver
cirrhosis, the prevalence of hyponatremia at a serum
sodium concentration ≤135 mmol/L was 47.9%, and that
of severe hyponatremia at a serum sodium concentration
≤130 mmol/L was 27.1%. These results were similar to
the overseas reports. In fact, the severity of hyponatremia,
particularly at serum sodium concentrations ≤130
mmol/L, corresponded to higher risks for developing
ascites, hepatic encephalopathy, spontaneous bacterial
peritonitis, hepatic hydrothorax, severe ascites, and
severe hepatic encephalopathy, compared with the
Figure 1. Kaplan-Meier analysis of the cumulative survival rate
according to the serum sodium concentration. 
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Table 4. Severity of complications by serum sodium concentration
Severity ≤130 mmol/L 131-135 mmol/L ≥136 mmol/L p value
(n=51) (n=39) (n=98)
Ascites 0.044
Grade 1, 2 10 12 28
Grade 3 35 22 44
Esophageal varix 0.223
F1 17 11 12
F2 8 7 34
F3 17 12 34
Hepatic encephalopathy 0.003
Grade 1, 2 14 12 21
Grade 3, 4 8 2 3
Table 5. Odds ratios for complications of cirrhosis according to serum sodium concentration
Complication 131-135 mmol/L (95% CI) ≤130 mmol/L (95% CI)
Ascites 2.456 (0.067-5.714) 2.708 (1.034-7.092)
Hepatic encephalopathy 1.727 (0.776-3.843) 2.339 (1.138-4.808)
Spontaneous bacterial peritonitis 2.278 (0.958-5.413) 2.562 (1.162-5.653)
Hepatic hydrothorax 3.382 (0.967-11.821) 5.723 (1.689-17.336)
Severe ascites (grade 3) 1.588 (0.752-3.354) 2.685 (1.316-5.477)
Hepatic encephalopathy (grade >3) 1.712 (0.275-10.601) 5.891 (1.49-23.3)
CI, confidence interval.Kim JH, et al. Clinical significance of serum sodium level in liver cirrhosis    111
risks in patients with a serum sodium ≥136 mmol/L.
In agreement with previous reports, serum sodium
concentration was not associated with the presence of
varices. Furthermore, there was no significant difference
in the incidences of hepatorenal syndrome and bacterial
infections, except for spontaneous bacterial peritonitis,
among the three serum sodium concentration groups. It is
possible that no significance was found owing to a lack of
statistical power based on the small number of patients
with hepatorenal syndrome (n=6) or infection (n=15).
Currently, many ongoing studies are examining the
pathophysiology of hyponatremia accompanied by liver
cirrhosis, and dilutional hyponatremia has been con-
sidered the most plausible pathophysiology [10]. In
animal experiments where portal hypertension was
induced, the concentration of nitric oxide (NO), with its
powerful vasodilatory action, was increased; NO is also
increased in patients with portal hypertension. Owing to
the vasodilatory effect of increased NO and the lower
effective circulating blood volume in these patients,
anti-diuretic hormone secretion is facilitated with the
mediation of baroreceptors, despite the presence of a
hypo-osmotic environment. The increased level of anti-
diuretic hormones lowers solute-free water excretion,
leading to dilutional hyponatremia [10].
In the current study, the risks for complications such
as severe ascites, spontaneous bacterial peritonitis,
hepatic hydrothorax, and hepatic encephalopathy were
increased at low serum sodium concentrations. With the
exception of hepatic encephalopathy, these complications
are believed to occur because of increased body fluid
resulting from the impairment of solute-free water
excretion. Hepatic encephalopathy occurs as a result of
severe hepatic dysfunction. In cases in which hypona-
tremia is concurrently present, however, the increased
intracellular concentration of glutamine due to hyper-
ammonemia, along with the adaptation to the hypo-
osmotic extracellular environment of hyponatremia,
increases the severity of hepatic encephalopathy, because
organic osmolytes such as myo-inositol become further
depleted in the cells [18]. The pathophysiology of hepato-
renal syndrome can also be explained by increased body
fluid resulting from the impairment of solute-free water
excretion. As mentioned earlier, however, our results did
not reach statistical significance, probably because only a
few patients with hepatorenal syndrome were enrolled in
the present study, in contrast to other studies [1,17]. The
presence and severity of varices did not correlate with
serum sodium concentration in the present study,
because development of varices depends on not the
excess of body water but the histological changes such as
the compression of venules by regenerating nodules,
perisinusoidal obstruction resulting from periportal
inflammation, or fibrosis and decreased sinusoidal
elasticity and diameter caused by collagen deposition in
the space of Disse. Further studies are needed to demon-
strate a significant relationship between the serum sodium
concentration and the above histological changes.
MELD scores were initially designed to predict survival
in patients who underwent elective placement of a trans-
jugular intrahepatic portosystemic shunt and are
currently used as an indicator of mortality in patients with
liver cirrhosis [19]. MELD scores are advantageous for
objectively predicting mortality in a homogeneous
manner because their constituent variables are objective
[20]. However, MELD scores have the disadvantage of not
reflecting the early deaths in patients with lower MELD
scores [2]. Many studies have been conducted recently to
examine the clinical usefulness of MELD-Na scores using
the serum sodium concentration as a prognostic indicator.
In the clinical setting, MELD-Na scores may be more
useful than MELD scores for the allocation of livers for
transplantation and for the prediction a short-term death
[21,22]. The clinical significance of the serum sodium
concentration was demonstrated in a retrospective study
that looked for factors associated with death prior to liver
transplantation in 507 patients with liver cirrhosis and
lower initial MELD scores. The persistent presence of
ascites and hyponatremia were independent risk factors in
patients with MELD scores lower than 21 points, and
MELD scores were a prognostic indicator only in other
patients [2]. In the current study, there was a significant
difference in the 3-year survival rate among the three
serum sodium concentration groups. However, the 3-year
survival rate was higher in patients with serum sodium
concentration ≤130 mmol/L than in those with serum
sodium concentration between 131 and 135 mmol/L.
These results indicate that the serum sodium
concentration alone cannot predict the survival rate in
patients with liver cirrhosis and that factors other than the
serum sodium concentration affect patient survival.
Further large-scale studies are warranted to explore these
factors.
One limitation of the current study was that it did not
assess the effect of serum sodium concentration on the
risks for developing complications but simply examined112 The Korean Journal of Internal Medicine Vol. 24, No. 2, June 2009
the concurrent presence of complications and sodium
levels in a retrospective analysis. Further prospective
studies are needed to determine the clinical significance of
hyponatremia and to identify its correlation with the
incidence of possible complications.
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